×

Healthcare

USD Analytics healthcare data solutions deliver information, analytics, and solutions for the world’s major medical device, pharmaceutical companies, financial markets, and governments. The company leverages its vast databases and industry expertise to present in-depth and up-to-date analyses of healthcare industries. The solution enables users to make efficient and informed decisions across the market. The Global Healthcare markets service presents an analysis of 60 countries with an updated outlook for the pharmaceutical industry. The reports in the service are updated every month and present healthcare expenditure, pharmaceutical sales, pharmaceutical goods trade balance, population forecasts, life expectancy, Consumer Price Inflation, GDP forecast, regulatory analysis, and company profiles. The Pipeline, Epidemiology, and Disease Market Outlook service presents disease pipeline reviews, clinical trial analysis, epidemiology reports, and disease market outlook for over 300 conditions. In addition, Analysis of marketed drugs, upcoming drug candidates, and other information is included in the research solutions. Further, the market size outlook and competitive analysis of medical devices, Healthcare IT, Analytics and Instrumentation, and the Biotechnology industry outlook are analyzed.

Healthcare
Report Name

Transcranial Magnetic Stimulation System Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Deep Transcranial Magnetic Stimulator, Repetitive Transcranial Magnetic Stimulator, Others), By Application (Alzheimer’s Disease, Depression, Parkinson’s Disease, Epilepsy, Others), By Age group (Adults, Children), Countries and Companies Report

Transcranial Magnetic Stimulation System Market is projected to register a 10.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD000437  |   No. of Pages: 189

Type 1 Diabetes Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Insulin Group (Long-acting, Rapid-acting, Regular or short-acting, Intermediate-acting), By Type (Insulins, Symlin), By Intake Duration (Split or mixed, Split or mixed variant, Multiple daily injections (MDI), Continuous subcutaneous insulin infusion (CSII)), Countries and Companies Report

Type 1 Diabetes Drugs Market is projected to register a 6.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022968  |   No. of Pages: 196

Alpha Emitter Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Diagnostic Products (SPECT (TC-99m, TL-201, GA-67, I-123, Others), PET (F-18, SR-82/RB-82, Others), By Therapeutic Products (Alpha Emitters (RA-223, Others), Beta Emitters (I-131, Y-90, SM-153, Re-186, Lu-117 , Others), Brachytherapy (Cesium-131,Iodine-125,Palladium-103, Iridium-192, Others), By Application (Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Bone Metastasis, Endocrine Tumor, Others), By End-user ( Hospitals & Clinics, Diagnostic Centers, Others), Countries and Companies Report

Alpha Emitter Market is projected to register a 12.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00012007  |   No. of Pages: 195

Surgical Display Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Low-end, Mid-end, High-end), Countries and Companies Report

Surgical Display Market is projected to register a 3.2% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD000771  |   No. of Pages: 192

Tyrosine Kinase Inhibitors Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (BCR-ABL Tyrosine Kinase Inhibitor, Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors, Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors, Others), By Application (Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer, Others), Countries and Companies Report

Tyrosine Kinase Inhibitors Market is projected to register a 8.6% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022970  |   No. of Pages: 191

Oral Antidiabetic Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Drug (Biguanides, Alpha-glucosidase inhibitors, Dopamine -D2 Receptor Agonist, Sodium-glucose Cotransport -2 (SGLT-2) inhibitor, Dipeptidyl Peptidase - 4 (DPP-4) Inhibitors, Sulfonylureas, Meglitinides), Countries and Companies Report

Oral Antidiabetic Drugs is projected to register a 5.3% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD0009498  |   No. of Pages: 205

Cell Culture Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Consumables, Instruments), By Application (Biopharmaceutical Production, Drug Development, Diagnostics, Tissue Culture & Engineering, Cell and Gene Therapy, Toxicity Testing, Others), Countries and Companies Report

Cell Culture is projected to register a 12.8% CAGR from 2024 to 2030, driven by North America, Europe, Asia Pacific, Latin America, Middle East, and Africa markets

Published On: November, 2024  |   Report Code: USD00024155  |   No. of Pages: 205

Migraine Drugs Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Treatment (Acute Treatment, Preventive Treatment), By Therapeutic Class (Triptans, Acetylcholine Inhibitors/ neurotoxins, Ergot Alkaloids, NSAIDs, Ditans, CGRP Small molecule antagonists, CGRP monoclonal antibodies, Others), By Route of Administration (Oral, Injectables, Others), Countries and Companies Report

Migraine Drugs Market is projected to register a 7.3% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00021327  |   No. of Pages: 187

Oral Cancer Therapeutics Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Product (Targeted Therapy, Chemotherapy), By End-User (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Stores), Countries and Companies Report

Oral Cancer Therapeutics Market is projected to register a 5.7% CAGR from 2024 to 2030. Geographically, the market is classified into major regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

Published On: November, 2024  |   Report Code: USD00022614  |   No. of Pages: 203

Intrauterine Devices Market Size, Share, Trends, Growth Outlook, and Opportunities to 2030- By Type (Hormonal IUD, Copper IUD), By Distribution Channel (Hospital, Gynecology Clinics, Community Health Care Centers, Others), Countries and Companies Report

Global Intrauterine Devices Market Size is valued at $4.9 Billion in 2024 and is forecast to register a growth rate (CAGR) of 3.9% to reach $6.7 Billion by 2032.

Published On: November, 2024  |   Report Code: USD00028760  |   No. of Pages: 185

USD Analytics

USD Analytics is a leading information and analytics provider for customers across industries worldwide.


Useful Links

Contact Us